HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplementary Figure Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Google Scholar Articles by Osiowy, C. Articles by Villeneuve, J.-P. PubMed PubMed Citation Articles by Osiowy, C. Articles by Villeneuve, J.-P. Agricola Articles by Osiowy, C. Articles by Villeneuve, J.-P.

Hepatitis B virus genotype G epidemiology and co-infection with genotype A in Canada

Diane Gordon^1,

¹ Bloodborne Pathogens and Hepatitis, National Microbiology Laboratory, Winnipeg, MB, Canada
² Section of Hepatology, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada
³ Hôpital Saint Luc du Centre Hospitalier, Universitaire de Montréal, Montréal, QC, Canada

Correspondence
Carla Osiowy
carla_osiowy{at}phac-aspc.gc.ca

Hepatitis B virus (HBV) genotype G (HBV/G) is an unusual variant, and little is known about its epidemiology and natural history, particularly the requirement for a co-infecting HBV genotype and their relationship during infection. This study investigated the quasispecies nature of co-infecting genotypes in 39 samples collected over a 6 year period from 13 HBV/G-infected patients. HBV/G infections were found to occur predominantly in males (92 %) and were primarily associated with male homosexual sex (67 %). All patients were infected with HBV/G and HBV/A, or a recombinant HBV/A/G strain. Co-infecting genotypic prevalence was often observed to fluctuate over time, with periods of HBV/G monoinfection in some patients. The average sequence divergence among Canadian HBV/G strains was 1.57±0.62 %. Thus, all HBV/G infections in Canada occur in the context of co-infection or recombination with HBV/A, and strains display increased sequence divergence compared with all known HBV/G sequences described to date.

Present address: Applied Biosafety Research Program, National Microbiology Laboratory, Winnipeg, MB, Canada.

The GenBank/EMBL/DDBJ accession numbers for the sequences reported in this paper are EU833889, EU833890 and EU833892–EU833930.

A supplementary figure is available with the online version of this paper.